Drug Profile
INBRX 101
Alternative Names: AAT-Fc; AAT-IgG-Fc; AT-292; INBRX-101; rhAAT-FcLatest Information Update: 06 Mar 2024
Price :
$50
*
At a glance
- Originator Inhibrx
- Class Recombinant fusion proteins
- Mechanism of Action Alpha 1-antitrypsin replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Alpha 1-antitrypsin deficiency